Cancer biotech raising $20m after delaying Nasdaq float
SYDNEY: Sydney-based biotech EnGeneIC is tapping investors to raise $20 million in bridging ... read more
SYDNEY: Sydney-based biotech EnGeneIC is tapping investors to raise $20 million in bridging ... read more